The hallmark of Parkinson’s disease is the degeneration of dopaminergic neurons in the substantia nigra pars compacta. Histological studies have also shown degeneration at several different levels of the brain. Modern MRI approaches have allowed detecting changes in these regions in patients with Parkinson’s disease. This presentation will review recent advances in MRI biomarker research in Parkinson’s disease and their use to study brainstem and basal forebrain lesions in Parkinson’s disease in relation to clinical symptoms.

More information

Wednesday, February 13, 2019
16:00 - 17:00
Loyola Jesuit Hall and Conference Centre
7141 Sherbrooke St W.,
Room RF 110

Presented by:
Dr. Stephane Lehericy
Sorbonne University

Everyone is welcome. This event is free of charge. No registration required.
e in relation to clinical symptoms.